AST-OPC1 not checked
Lineage Cell Therapeutics, Inc. · OPC1
FollowEvery change as it happens, and a Monday email
Trials
1 active
2 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “One injection of 10 million LCTOPC1 cells will be delivered to the target injection site of the damaged spinal tissue.”In the company’s words, NCT06841770 on ClinicalTrials.gov
- Tested for
- Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Spinal Cord Injury, Acute, Spinal Cord Injury, Spinal Cord Injury, Chronic
- Main trialPhase 1
- “The DOSED clinical study evaluates the safety and utility of a novel delivery device to deliver LCTOPC1, a cell therapy, to the spinal cord of patients with a spinal cord injury (SCI). LCTOPC1 is designed to replace or support cells that are absent or dysfunctional due to traumatic injury, with a goal to help improve the quality of life and restore or augment functional activity in persons suffering from a traumatic cervical or thoracic injuries.”In the company’s words, NCT06841770 on ClinicalTrials.gov
- Other names
- OPC1
Other drugs for Spinal Cord Injury
- VibegronUrovant Sciences GmbH · Phase 2/3
- EG110ACyllene Therapeutics · Phase 1/2
- Neural precursor cells derived from human embryonic stem cell lineS.Biomedics Co., Ltd. · Phase 1/2
- XS228XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Phase 2
- NG004NovaGo Therapeutics AG · Phase 1
- EC5026EicOsis Human Health Inc. · Phase 1
Coming up1
- 10 Aug 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 10 Aug 2027 | A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury | |
| Phase 1/2Completed | Dec 2018 | Dose Escalation Study of AST-OPC1 in Spinal Cord Injury |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026